The partnership combines Quotient's specialized early clinical and drug development capabilities with Lindus’ patient recruitment expertise and later-stage trial delivery.
Founded in 2014, UBI Pharma Inc. leads in sterile injectable manufacturing in Taiwan. We take pride in being routinely inspected by US FDA, Japan PMDA, UK MHRA and more. With proven track record and extensive expertise, we offer one-stop shop CDMO/CMO services, to transform your idea into commercialized product rapidly without compromising quality.